IRIS
FONTI, ROSA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.134
NA - Nord America 2.454
EU - Europa 1.853
SA - Sud America 308
AF - Africa 115
OC - Oceania 5
Totale 7.869
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.348
SG - Singapore 1.428
RU - Federazione Russa 902
VN - Vietnam 583
CN - Cina 577
IT - Italia 338
BR - Brasile 233
HK - Hong Kong 220
DE - Germania 101
FR - Francia 95
BD - Bangladesh 81
FI - Finlandia 61
IE - Irlanda 57
CA - Canada 56
UA - Ucraina 49
GB - Regno Unito 47
BE - Belgio 45
CI - Costa d'Avorio 43
NL - Olanda 43
JP - Giappone 42
KR - Corea 38
IN - India 36
SE - Svezia 33
AR - Argentina 29
PH - Filippine 22
MX - Messico 20
IQ - Iraq 19
ZA - Sudafrica 16
AT - Austria 13
EC - Ecuador 13
LT - Lituania 13
PL - Polonia 13
TH - Thailandia 13
ES - Italia 11
CO - Colombia 10
TR - Turchia 9
TW - Taiwan 9
EG - Egitto 8
DZ - Algeria 7
MA - Marocco 7
PY - Paraguay 7
TN - Tunisia 7
KE - Kenya 6
MY - Malesia 6
VE - Venezuela 6
CL - Cile 5
DO - Repubblica Dominicana 5
HN - Honduras 5
JM - Giamaica 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
ID - Indonesia 4
KZ - Kazakistan 4
PK - Pakistan 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
CG - Congo 3
CZ - Repubblica Ceca 3
IL - Israele 3
IR - Iran 3
IS - Islanda 3
NP - Nepal 3
PE - Perù 3
SN - Senegal 3
UZ - Uzbekistan 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
AU - Australia 2
BB - Barbados 2
BG - Bulgaria 2
BW - Botswana 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
HU - Ungheria 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
MD - Moldavia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
CV - Capo Verde 1
DM - Dominica 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
Totale 7.853
Salva come PNG Salva come JPEG
Città #
Singapore 715
San Jose 410
Moscow 227
Hong Kong 214
Chandler 212
Ashburn 174
Beijing 165
Ho Chi Minh City 162
Hanoi 129
Santa Clara 95
Naples 93
Hefei 88
The Dalles 73
Lauterbourg 66
Millbury 60
Jacksonville 56
Los Angeles 52
Boston 48
Princeton 48
New York 42
Brussels 39
Nanjing 39
Tokyo 38
Amsterdam 36
Buffalo 32
Da Nang 32
Munich 31
Haiphong 30
Redondo Beach 30
Des Moines 27
Woodbridge 27
Napoli 22
Council Bluffs 21
Milan 21
Dallas 20
Orem 20
Ottawa 20
Seattle 20
Seoul 20
Wilmington 20
Chicago 18
Nuremberg 18
São Paulo 18
Tianjin 17
Rome 16
Dublin 15
San Francisco 15
Biên Hòa 13
Lawrence 13
Changsha 12
Hebei 12
Nanchang 12
Brooklyn 11
Hải Dương 11
Frankfurt am Main 10
London 10
Montreal 10
Charlotte 9
Houston 9
Phoenix 9
Shenyang 9
Atlanta 8
Denver 8
Hangzhou 8
Helsinki 8
Mexico City 8
Poplar 8
Toronto 8
Warsaw 8
Falls Church 7
Kochi 7
Stockholm 7
Turku 7
Baghdad 6
Boardman 6
Brescia 6
Can Tho 6
Dong Ket 6
Falkenstein 6
Kronberg 6
Thái Bình 6
Thái Nguyên 6
Vienna 6
Caserta 5
Chennai 5
Dearborn 5
Lappeenranta 5
Manchester 5
Nairobi 5
Norwalk 5
Palermo 5
Queens 5
Turin 5
Washington 5
Điện Bàn 5
Baku 4
Contagem 4
Courcelles 4
Curitiba 4
Jiaxing 4
Totale 4.173
Salva come PNG Salva come JPEG
Nome #
2-deoxy-2[F-18] fluoro-D-GLUCOSE POSITRON EMISSION TOMOGRAPHY Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma 187
Heterogeneity of SSTR2 expression assessed by 68Ga-DOTATOC PET/CT using coefficient of variation in patients with neuroendocrine tumors 184
Machine Learning and Texture Analysis of [18F]FDG PET/CT Images for the Prediction of Distant Metastases in Non-Small-Cell Lung Cancer Patients 170
Evaluation of metabolic response with 18F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors. 156
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study 152
Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma 152
Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi-Center Real-Life Study 144
Heterogeneity of glycolytic phenotype determined by 18F-FDG PET/CT using coefficient of variation in patients with advanced non-small cell lung cancer 143
Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms 141
Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors 136
2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis 135
Coefficient of variation in metastatic lymph nodes determined by 18F-FDG PET/CT in patients with advanced NSCLC: combination with coefficient of variation in primary tumors 132
Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer 128
Multimodal imaging with 18F-FDG-PET/CT and 111In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma 122
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma 121
Metabolic tumor volume assessed by 18F-FDG-PET/CT for the prediction of outcome in patients with multiple myeloma 119
18F-FDG-PET/CT, 99mTc-MIBI and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study 119
Washout of 99mTc-Sestamibi in predicting response to chemotherapy in patients with multiple myeloma. 118
Oncologia 118
The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study 118
Functional imaging of multidrug resistance in breast cancer. 117
Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patients 116
Non-canonical role of PDK1 as a negative regulator of apoptosis through macromolecular complexes assembly at the ER-mitochondria interface in oncogene-driven NSCLC 113
Neutrophil extracellular traps as an adhesion substrate for different tumor cells expressing RGD-binding integrins. 110
Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis. 110
Visual and volumetric parameters by 18F-FDG-PET/CT: a head to head comparison for the prediction of outcome in patients with multiple myeloma 109
Bone scintigraphy and SPECT/CT in bisphosphonate-induced osteonecrosis of the jaw 108
Carcinoide timico in paziente affetta da sindrome da neoplasie endocrine multiple di tipo 1 (MEN1): ruolo dello screening radiologico e medico-nucleare 106
Nuclear imaging in cancer theranostic 106
Contrast enhanced multi-detector CT and MR findings of a well-differentiated pancreatic vipoma 106
A look into the future: the role of PSMA beyond prostate cancer 105
PET/CT in cancer research: from preclinical to clinical applications. 105
A Survey of surgical Pathology of the medistinum preliminary data from a multicenter study”. 104
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET. 104
Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1) 104
18F-FDG-PET/CT, 99mTc-MIBI and MRI in the evaluation of patients with multiple myeloma 102
F-18-FDG-PET/CT, 99mTC-MIBI and MRI in the evaluation of patients with multiple myeloma 102
Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy. 101
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma 101
99mTc-MIBI uptake in Bcl-2 overexpressing non-Hodgkin's lymphoma patients during drug-induced apoptosis. 100
Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcima 99
99mTc-MIBI in the evaluation of breast cancer biology 99
Combined imaging with 18F-FDG-PET/CT and 111In-labeled Octreotide SPECT for evaluation of thymic epithelial tumors 99
Brain metastases unresponsive to immunotherapy detected by 18F-FDG-PET/CT in a patient with melanoma 99
Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type 3. 97
18F-FDG-PET/CT in the evaluation of bone marrow infiltration in patients with multiple myeloma. 96
99mTc-MIBI uptake in breast cancer cells during early phases of apoptosis induction with Staurosporine 95
Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients 93
Detection of leptomeningeal involvement by 18F-FDG-PET/CT in a patient with non-Hodgkin lymphoma 92
What molecular imaging of cancer patients can teach us about COVID-19 90
Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma 89
Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine for Patients Aged 18-59 Years With Untreated Advanced Stage Classical Hodgkin Lymphoma: The Largest Real-Life Series From Southern Italy Cancer Centers 86
SPECT imaging of endoplasmic reticulum-mediated tumor response to gefitinib and erlotinib in lung cancer 86
PET-based volumetric biomarkers for risk stratification of non-small cell lung cancer patients 86
Preclinical imaging in targeted cancer therapies. 85
In vitro receptor imaging for characterization of human solid tumors. 85
Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. 82
Metabolic Tumor Volume assessed by 18F-FDG-PET/CT in the evaluation of plasma cell mass and prediction of outcome in patients with multiple myeloma. 82
Coordinate modulation of glycolytic enzymes and OXPHOS by imatinib in BCR-ABL driven chronic myelogenous leukemia cells. 77
Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy 77
Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography. 76
A reversible shift of driver dependence from EGFR to Notch1 in non-small cell lung cancer as a cause of resistance to tyrosine kinase inhibitors. 75
Reversal of Warburg effect and reactivation of oxidative phosphorylation by differential inhibition of EGFR signaling pathways in non-small cell lung cancer. 74
Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay 73
Evidence of brown fat activity in constitutional leanness. 73
Preclinical imaging for targeting cancer immune evasion 72
Texture Analysis of 68Ga-DOTATOC PET/CT Images for the Prediction of Outcome in Patients with Neuroendocrine Tumors 71
Molecular Imaging of drug resistance in cancer. 70
PET/CT in radiation oncology 70
Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography 69
Sentinel lymph node identification in breast cancer patients 66
Imaging of immunotherapy response in non-small cell lung cancer: challenges and perspectives. 62
Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomography 59
Ig antibody levels to Helicobacter pylori and histology of antral gastritis and duodenal ulcer: What is the correlation? 54
Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non-Small Cell Lung Cancer Detected by 18F-Fluorothymidine 54
99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors 53
Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 47
Metastasis to the Sellar/Suprasellar Region in a Patient with Endometrial Carcinoma Detected by 18F-FDG PET/CT 47
Bendamustine supercharge plus brentuximab vedotin as early salvage therapy following failure to obtain complete metabolic remission after two cycles of adriamycin–bleomycin–vinblastine–dacarbazine for classic Hodgkin lymphoma in patients aged ≤ 60 years: Long-term efficacy results of a retrospective multicentre study 40
Prognostic Value of Tumor Dissemination (Dmax) Derived from Basal 18F-FDG Positron Emission Tomography/Computed Tomography in Patients with Advanced Non-Small-Cell Lung Cancer 39
Non-invasive detection of epithelial mesenchymal transition phenotype and metastatic dissemination of lung cancer by liquid biopsy 31
Totale 7.993
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.104
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.104
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022346 7 1 7 1 7 9 6 7 48 14 88 151
2022/2023473 65 48 11 35 66 57 3 56 67 34 26 5
2023/2024359 16 42 39 23 23 15 19 71 14 13 57 27
2024/20251.963 101 113 6 19 49 100 235 137 113 217 715 158
2025/20264.267 379 288 401 392 841 166 405 281 528 293 127 166
2026/202746 46 0 0 0 0 0 0 0 0 0 0 0
Totale 7.993